IOTOD 2022

The 20th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place as a virtual event on the 11-12 May 2022.

The 2022 IOTOD faculty led an engaging two-day meeting, featuring international field experts speaking on multiple and emerging topics, such as: the changing patient profile, opioid analgesic dependence, opioid substitution therapy, the experience so far with long-acting buprenorphine formulations from the patients’ perspectives, and optimising best approaches to address viral hepatitis in PWIDs. 


The IOTOD conference partners with internationally-renowned faculty from a variety of backgrounds and specialities.

The faculty includes experts in treatment challenges faced in the COVID-era, opioid analgesia dependence, optimising virology care and much more.

Catriona Matheson

Professor in Substance Use, Stirling University


Professor Adrian Dunlop

Director and Senior Staff Specialist Hunter New England Local Health District Drug & Alcohol Clinical Services

Newcastle NSW, Australia

Dr Stephan Walcher

Director, Concept Centre for Addiction Medicine

Munich, Germany

Ms Cathryn Kemp

Author of ‘Coming Clean'


Maurice Dematteis

Head of the Department of Addictions, University Hospital of Grenoble

Grenoble, France

Professor Oscar D’Agnone

Consultant Psychiatrist; and Honorary Professor of the Faculty of Medical and Human Sciences, University of Manchester

Manchester, UK

John Marsden

Professor of Addiction Psychology, Addictions Department, King’s College London

London, UK

Mr Duncan Cairns

Chair of the Board of Directors, Aurora Project

London, UK

Nicholas Lintzeris

Drug and Alcohol Services, South-East Sydney Local Health District

Sydney, Australia

Dr Michael Frost

President/Medical Director

The Frost Medical Group, Pennsylvania, United States

Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire (NHSL)

Glasgow, Scotland

Professor Trish Hafford-Letchfield

Head Of School School of Social Work and Social Policy University of Strathclyde

Glasgow, Scotland

Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Professor Heino Stöver

Frankfurt University of Applied Sciences, Germany

Ashley Brown

Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London

London, UK


Manoeuvres in the fog: drug-drug interactions in OST
Practicalities of transitioning between opioid agonist treatments
New horizons for treatment: translating the latest research into clinical practice
Tailoring behavioural interventions: emerging evidence and practical implications
View all webcasts